Relmada Therapeutics, Inc. SEC filings RLMD

Relmada Therapeutics, Inc. has 606 filings in SEC EDGAR's recent list, going back to Nov 13, 2012. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (other events). The company's fiscal year ends on December 31.

Relmada Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Other events
Sep 8, 2026 Sep 3, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jul 28, 2026 Jul 28, 2026
S-8 Employee stock plan registration Jun 18, 2026 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 28, 2026 May 27, 2026
S-3ASR Automatic shelf registration May 13, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2026 May 12, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
DEFA14A Additional proxy material Apr 17, 2026 —
DEF 14A Proxy statement Apr 17, 2026 May 27, 2026
EFFECT Filing Apr 9, 2026 —
424B3 Prospectus Apr 9, 2026 —
CORRESP Letter to the SEC Apr 7, 2026 —
UPLOAD Letter from the SEC Apr 7, 2026 —
PRE 14A Preliminary proxy statement Apr 6, 2026 Apr 6, 2026
S-3 Shelf registration Apr 3, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 20, 2026 Mar 19, 2026
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Mar 9, 2026 Mar 9, 2026
424B5 Prospectus supplement Jan 30, 2026 —
8-K Current report
Officer or director change
Dec 15, 2025 Dec 12, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Nov 5, 2025 Nov 4, 2025
424B5 Prospectus supplement Nov 5, 2025 —
FWP Free writing prospectus Nov 4, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Nov 4, 2025 Nov 4, 2025
8-K Current report
Regulation FD disclosure
Sep 17, 2025 Sep 17, 2025
8-K Current report
Other events
Sep 16, 2025 Sep 15, 2025
8-K Current report
Regulation FD disclosure
Sep 10, 2025 Sep 10, 2025
8-K Current report
Regulation FD disclosure
Sep 2, 2025 Aug 29, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Listing notice
Jul 23, 2025 Jul 22, 2025
8-K Current report
Agreement ended
Jul 10, 2025 Jul 7, 2025
8-K Current report
Regulation FD disclosure
Jun 18, 2025 Jun 17, 2025
S-8 Employee stock plan registration Jun 13, 2025 —
8-K Current report
Shareholder vote results
May 27, 2025 May 23, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Auditor change
May 12, 2025 May 8, 2025
424B5 Prospectus supplement Apr 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Apr 28, 2025 Apr 28, 2025
DEFA14A Additional proxy material Apr 11, 2025 —
DEF 14A Proxy statement Apr 11, 2025 May 23, 2025
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 26, 2025 Mar 24, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Feb 6, 2025 Feb 3, 2025
8-K Current report
Listing notice
Jan 27, 2025 Jan 21, 2025
8-K Current report
Officer or director change
Jan 6, 2025 Jan 1, 2025
8-K Current report
Regulation FD disclosure
Dec 9, 2024 Dec 9, 2024
8-K Current report
Regulation FD disclosure
Dec 4, 2024 Dec 4, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
EFFECT Filing Sep 12, 2024 —
CORRESP Letter to the SEC Sep 11, 2024 —
UPLOAD Letter from the SEC Sep 6, 2024 —
S-3 Shelf registration Aug 30, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Shareholder vote results
May 30, 2024 May 24, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
DEFA14A Additional proxy material Apr 9, 2024 —
DEF 14A Proxy statement Apr 9, 2024 May 24, 2024
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Officer or director change
Jan 11, 2024 Jan 5, 2024
8-K Current report
Regulation FD disclosure
Jan 4, 2024 Jan 4, 2024
8-K Current report
Officer or director change
Jan 3, 2024 Jan 3, 2024
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Regulation FD disclosure
Oct 11, 2023 Oct 11, 2023
8-K Current report
Other events
Oct 10, 2023 Oct 10, 2023
8-K Current report
Other events
Oct 4, 2023 Oct 4, 2023
8-K Current report
Regulation FD disclosure
Sep 20, 2023 Sep 20, 2023
8-K Current report
Officer or director change
Sep 6, 2023 Sep 5, 2023
8-K Current report
Other events
Aug 10, 2023 Aug 10, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
S-8 Employee stock plan registration Jun 21, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
May 25, 2023 May 25, 2023
8-K Current report
Other events
May 15, 2023 May 15, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Other events
Apr 19, 2023 Apr 19, 2023
DEFA14A Additional proxy material Mar 31, 2023 —
DEF 14A Proxy statement Mar 31, 2023 May 25, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
8-K Current report
Material agreement, Officer or director change
Jan 17, 2023 Jan 12, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Material agreement, Other events
Jan 5, 2023 Jan 1, 2023
8-K Current report
Material agreement
Dec 28, 2022 Dec 27, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 7, 2022 Dec 7, 2022
8-K Current report
Other events
Nov 14, 2022 Nov 11, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2022 Nov 10, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 13, 2022 Oct 13, 2022
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Sep 22, 2022 Sep 21, 2022
8-K Current report
Other events
Sep 20, 2022 Sep 20, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 1, 2022 May 25, 2022
8-K Current report
Results of operations, Other events
May 5, 2022 May 5, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
DEF 14A Proxy statement Apr 11, 2022 May 25, 2022
S-3ASR Automatic shelf registration Apr 7, 2022 —
PRE 14A Preliminary proxy statement Mar 31, 2022 Mar 31, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 23, 2022 Mar 23, 2022
8-K Current report
Other events
Mar 7, 2022 Mar 7, 2022
8-K Current report
Regulation FD disclosure, Other events
Feb 23, 2022 Feb 23, 2022
8-K Current report
Regulation FD disclosure
Dec 22, 2021 Dec 22, 2021
8-K Current report
Other events
Dec 20, 2021 Dec 20, 2021
8-K Current report
Material agreement
Dec 13, 2021 Dec 8, 2021
424B5 Prospectus supplement Dec 10, 2021 —
424B5 Prospectus supplement Dec 8, 2021 —
8-K Current report
Other events
Dec 7, 2021 Dec 7, 2021
8-K Current report
Other events
Nov 23, 2021 Nov 23, 2021
8-K Current report
Other events
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Other events
Oct 7, 2021 Oct 4, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Material agreement
Jul 20, 2021 Jul 16, 2021
S-8 Employee stock plan registration Jul 6, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2021 May 20, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
DEF 14A Proxy statement Mar 31, 2021 May 20, 2021
10-K Annual report Mar 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 23, 2021 Mar 23, 2021
8-K Current report
Regulation FD disclosure
Mar 15, 2021 Mar 15, 2021
8-K Current report
Regulation FD disclosure
Mar 15, 2021 Mar 15, 2021
8-K Current report
Other events
Jan 7, 2021 Jan 6, 2021
8-K Current report
Officer or director change
Jan 5, 2021 Dec 31, 2020
8-K Current report
Other events
Dec 14, 2020 Dec 14, 2020
8-K Current report
Other events
Dec 8, 2020 Dec 7, 2020
8-K Current report
Other events
Nov 16, 2020 Nov 16, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Other events
Oct 27, 2020 Oct 27, 2020
EFFECT Filing Aug 21, 2020 —
CORRESP Letter to the SEC Aug 19, 2020 —
UPLOAD Letter from the SEC Aug 18, 2020 —
S-3 Shelf registration Aug 12, 2020 —
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Other events
Jun 3, 2020 Jun 2, 2020
424B5 Prospectus supplement May 15, 2020 —
10-Q Quarterly report May 15, 2020 Mar 31, 2020
8-K/A Amended current report
Officer or director change
Apr 6, 2020 Mar 6, 2020
10-KT Transition report Mar 26, 2020 Dec 31, 2019
8-K Current report
Material agreement, Officer or director change
Mar 12, 2020 Mar 6, 2020
8-K Current report
Material agreement, Shareholder vote results
Mar 9, 2020 Mar 6, 2020
DEFA14A Additional proxy material Feb 28, 2020 —
DEF 14A Proxy statement Jan 31, 2020 Mar 6, 2020
8-K Current report
Material agreement, Officer or director change
Jan 10, 2020 Jan 9, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Other events
Dec 26, 2019 Dec 19, 2019
8-K Current report
Material agreement
Dec 6, 2019 Dec 3, 2019
424B5 Prospectus supplement Dec 5, 2019 —
424B5 Prospectus supplement Dec 3, 2019 —
8-K Current report
Material agreement, Other events
Dec 3, 2019 Nov 27, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
424B3 Prospectus Nov 1, 2019 —
EFFECT Filing Oct 31, 2019 —
EFFECT Filing Oct 31, 2019 —
CORRESP Letter to the SEC Oct 30, 2019 —
CORRESP Letter to the SEC Oct 28, 2019 —
S-3/A Amendment no. 1 to form s-3 Oct 28, 2019 —
POS AM Registration statement Oct 25, 2019 —
UPLOAD Letter from the SEC Oct 25, 2019 —
424B3 Prospectus Oct 24, 2019 —
EFFECT Filing Oct 23, 2019 —
CORRESP Letter to the SEC Oct 21, 2019 —
8-K Current report
Regulation FD disclosure, Other events
Oct 21, 2019 Oct 15, 2019
S-3 Shelf registration Oct 18, 2019 —
8-K Current report
Other events
Oct 18, 2019 Oct 17, 2019
CORRESP Letter to the SEC Oct 17, 2019 —
S-1/A Amended registration statement Oct 17, 2019 —
UPLOAD Letter from the SEC Oct 16, 2019 —
CORRESP Letter to the SEC Oct 11, 2019 —
S-1/A Amended registration statement Oct 11, 2019 —
D Filing Oct 8, 2019 —
CERT Filing Oct 8, 2019 —
8-A12B Form 8-a12b Oct 8, 2019 —
8-K Current report
Other events
Oct 1, 2019 Oct 1, 2019
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 27, 2019 Sep 26, 2019
10-K Annual report Sep 24, 2019 Jun 30, 2019
SEC STAFF ACTION Filing Sep 23, 2019 —
UPLOAD Letter from the SEC Aug 20, 2019 —
S-1 Registration statement Aug 12, 2019 —
8-K Current report
Material agreement, Officer or director change
Jul 29, 2019 Jul 29, 2019
8-K/A Amended current report
Other events
Jul 18, 2019 Jul 17, 2019
8-K Current report
Other events
Jul 17, 2019 Jul 17, 2019
D/A Filing Jul 10, 2019 —
D Filing Jun 27, 2019 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jun 20, 2019 Jun 14, 2019
D Filing May 16, 2019 —
S-8 Employee stock plan registration May 15, 2019 —
10-Q Quarterly report May 15, 2019 Mar 31, 2019
8-K Current report
Material agreement, Bylaw or fiscal year change
Apr 15, 2019 Apr 12, 2019
424B3 Prospectus Mar 5, 2019 —
EFFECT Filing Mar 1, 2019 —
8-K Current report
Shareholder vote results
Feb 28, 2019 Feb 27, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RLMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Coral Gables, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1553643
Former names
CAMP NINE, INC. (until Jul 14, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.